The Human Papillomavirus (HPV) vaccine is globally recognised as a proven tool for preventing cervical cancer and other HPV-related diseases.
Yet in Nigeria, where cervical cancer remains one of the leading causes of cancer deaths among women, uptake of the vaccine is far from widespread. A new HPV Social Listening Insights Report by Nigeria Health Watch reveals why: misinformation, stigma, high costs, and knowledge gaps are keeping millions of Nigerians away from this life-saving intervention.
EDITOR’S PICKS
The report, which tracked 881 HPV-related conversations across X (formerly Twitter), Facebook, YouTube and other platforms between August 1 and 14, 2025, shows that online sentiment remains largely unfavourable. Those discussions reached over 3.3 million people and generated more than 8,600 engagements, but the tone of engagement was discouraging, according to the report.
Almost half of the conversations reflected mistrust and fear, while another 50 percent revealed uncertainty or limited knowledge. Only five percent of the discussions showed openly positive attitudes toward the vaccine.
This pattern underscores how digital platforms are amplifying vaccine hesitancy. Misleading claims about infertility, cancer risks, and even death were widely circulated, while some narratives framed Africa as a testing ground for unsafe vaccines. Others confused HPV with HIV, further clouding public understanding.
“Such myths fuel distrust and deepen stigma, with some posts warning people to avoid vaccines promoted by public figures or international health organisations,” the report states.
The weight of misinformation and stigma
Misinformation alone is powerful enough to derail public health campaigns, but when combined with stigma, the challenge intensifies. The report highlights that many Nigerians view an HPV diagnosis as a source of shame within relationships, with some fearing rejection or discrimination.
Concerns also extend to fears of being unknowingly used in clinical trials. These suspicions are not new: Nigeria’s history of controversial vaccine trials and distrust of foreign-backed interventions has created fertile ground for conspiracy theories. The HPV vaccine, despite its proven safety record, has become caught in this web of suspicion.
Knowledge gaps complicate uptake
Beyond deliberate disinformation, gaps in basic knowledge about HPV persist. Many Nigerians still lack clear information on how the virus spreads or its link to multiple cancers affecting both men and women. Misconceptions such as describing HPV vaguely as “a sickness” show that the conversation is missing critical educational elements.
Equally, confusion about who needs the vaccine remains widespread. The question “Do boys also need protection?” appeared frequently in online debates. Without broad awareness that HPV affects both sexes and contributes to cancers beyond the cervix, uptake will remain low.
Affordability: A barrier too high
Even when trust and knowledge barriers are addressed, economic realities present another wall. The report notes that the HPV vaccine costs up to ₦120,000 for three doses in private facilities. In a country where nearly half the population lives in poverty, such costs make the vaccine unattainable for most households.
Public demand for clarity on whether vaccines are free in government hospitals reflects widespread financial strain. Without subsidies or integration into Nigeria’s routine immunisation schedule, access will remain restricted to wealthier families, worsening existing health inequalities.
Recommendations for Change
The report recommends a multi-pronged response. Government health agencies must take the lead in subsidising vaccine costs and integrating HPV vaccination into routine care. Civil society and community leaders should help debunk myths, while trusted figures—religious leaders, health workers, and survivors—can serve as credible messengers.
It also suggests that survivor stories be amplified to humanise the issue and reduce stigma, while practical, location-specific information about where and how to access vaccination should be widely shared.
FURTHER READING
Experts warn that unless these barriers are tackled, HPV-related cancers—particularly cervical cancer—will remain a major public health threat. With thousands of Nigerian women dying annually from preventable cancers, the stakes are high.
Philip Ibitoye is a Special Correspondent with EKO HOT BLOG. Click here to find daily analysis and critical insight on trending issues in Lagos and other parts of Nigeria.
Click here to watch the video of the week below:
